Volume 14 - Issue 6 - June, 2002
Original Contribution
08/01/2008
Timuçin Altin, MD; Cagdas Ozdöl Sadi, MD; Sadi Guleç, MD; Gülgün Pamir, MD; Yusuf Atmaca, MD; Dervis Oral, MD
Intracoronary stents have been a major milestone in interventional cardiology ever since two large, randomized trials1,2 documented that they reduced restenosis and repeat revascularization rates and increased event-free survival at 6 months....
Intracoronary stents have been a major milestone in interventional cardiology ever since two large, randomized trials1,2 documented that they reduced restenosis and repeat revascularization rates and increased event-free survival at 6 months....
Intracoronary stents have been a...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Marie-Claude Morice, MD, FESC, FACC; Christophe Loubeyre, MD
The development of pre-mounted stents, as well as numerous technical enhancements, have contributed to the improvement of stent profile, flexibility and safety. Stent placement without predilation has become feasible and can virtually be...
The development of pre-mounted stents, as well as numerous technical enhancements, have contributed to the improvement of stent profile, flexibility and safety. Stent placement without predilation has become feasible and can virtually be...
The development of pre-mounted...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Yusuf Atmaca, MD; Dervis Oral, MD; Timuçin Altin, MD; Cagdas Ozdöl Sadi, MD; Sadi Guleç, MD; Gülgün Pamir, MD
Intracoronary stents have been a major milestone in interventional cardiology ever since two large, randomized trials1,2 documented that they reduced restenosis and repeat revascularization rates and increased event-free survival at 6 months....
Intracoronary stents have been a major milestone in interventional cardiology ever since two large, randomized trials1,2 documented that they reduced restenosis and repeat revascularization rates and increased event-free survival at 6 months....
Intracoronary stents have been a...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Shigenori Ito, MD; Takahiko Suzuki, MD; Hiroshi Suzumura, MD; Hiroaki Hosokawa, MD; Tatsuya Fukutomi, MD; Makoto Itoh, MD
Although acute and late results of coronary intervention have been obtained by coronary angiography and this method might be sufficient for daily practice, angiography is a luminology1 and cannot reveal changes in vessel and plaque volume. On...
Although acute and late results of coronary intervention have been obtained by coronary angiography and this method might be sufficient for daily practice, angiography is a luminology1 and cannot reveal changes in vessel and plaque volume. On...
Although acute and late results...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Peter Braun, MD; Erika Stroh, MD; Karl-Wilhelm Heinrich, MD
In comparison to conventional balloon dilatation, intracoronary stents reduce the rate of restenoses and peri-interventional complications for specific vessel segments and in vessels with a diameter of > 3 mm. The lower rate of restenoses...
In comparison to conventional balloon dilatation, intracoronary stents reduce the rate of restenoses and peri-interventional complications for specific vessel segments and in vessels with a diameter of > 3 mm. The lower rate of restenoses...
In comparison to conventional...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Massimo Chessa, MD, PhD; Roberta Margherita Bini, MD; Gianfranco Butera, MD, PhD; Mario Carminati, MD; Qi-Ling Cao, MD; Ziyad M. Hijazi, MD, MPH
Surgical closure of congenital or acquired [post-myocardial infarction (MI)] muscular ventricular septal defects (MVSD) is still associated with significant mortality and long-term morbidity.1,2 Different surgical approaches have been...
Surgical closure of congenital or acquired [post-myocardial infarction (MI)] muscular ventricular septal defects (MVSD) is still associated with significant mortality and long-term morbidity.1,2 Different surgical approaches have been...
Surgical closure of congenital...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
George D. Dangas, MD, PhD; Costantino O. Costantini, MD
In-stent restenosis (ISR) is the most important limitation to current percutaneous coronary intervention (PCI) practice. Intimal hyperplasia has been well defined as the principal mechanism involved in recurrence after stent implantation....
In-stent restenosis (ISR) is the most important limitation to current percutaneous coronary intervention (PCI) practice. Intimal hyperplasia has been well defined as the principal mechanism involved in recurrence after stent implantation....
In-stent restenosis (ISR) is the...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
08/01/2008
Xavier Lyon, MD; Stephan Wicky, MD; L. Kappenberger, MD
Coronary artery anomalies are rare and represent about 1.3% of coronary angiograms.1,2 They are usually asymptomatic. They can be clinically significant in a case of single coronary artery anomaly, as the left main artery (LMA) courses in...
Coronary artery anomalies are rare and represent about 1.3% of coronary angiograms.1,2 They are usually asymptomatic. They can be clinically significant in a case of single coronary artery anomaly, as the left main artery (LMA) courses in...
Coronary artery anomalies are...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Matthew H. Otten, BA; Kent Dauterman, MD; Thomas A. Ports, MD; Tony M. Chou, MD; Michael Gibson, MD, MS; Andrew D. Michaels, MD, MAS; Mark Appleby, MD
Intracoronary calcium channel blockers have been administered during percutaneous coronary interventions (PCI) for the management of reduced coronary flow due to microvascular dysfunction.1–3 More recent studies have shown that intracoronary...
Intracoronary calcium channel blockers have been administered during percutaneous coronary interventions (PCI) for the management of reduced coronary flow due to microvascular dysfunction.1–3 More recent studies have shown that intracoronary...
Intracoronary calcium channel...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Dean J. Kereiakes, MD, FACC, MSCAI; John J. Young, MD; Joseph K. Choo, MD; Thomas M. Broderick, MD
In the current issue of the Journal, Michaels et al.1 provide convincing evidence that the prophylactic administration of verapamil prior to percutaneous coronary intervention (PCI) of saphenous vein grafts
See Michaels et al. on pages...
In the current issue of the Journal, Michaels et al.1 provide convincing evidence that the prophylactic administration of verapamil prior to percutaneous coronary intervention (PCI) of saphenous vein grafts
See Michaels et al. on pages...
In the current issue of the...
08/01/2008
Journal of Invasive Cardiology
